Column

Healthcare leaders should understand the fundamental differences between health insurers and hospital systems in terms of financing structures and key performance metrics.

CMS’s proposal to reduce rates for 340B-covered entities for separately payable outpatient drugs may indicate the Trump administration may take an aggressive approach to healthcare policy.

For healthcare leaders, the effort to promote enhanced value should involve not just to searching for consensus but actively molding it.

Consumerism may be slipping lower on healthcare leaders’ priority lists. Although it may not seem urgent, it’s more important than ever. Here’s why.

Hospitals should reassess the private placement debt they accrued in the recent constrained lending market to determine their best options now that the market has loosened. 

When considering a merger or affiliation, healthcare leaders can examine the proposal from a personal vantage point, as if the discussions of the transaction were a dialogue between individuals.

Social determinants of health are becoming increasingly relevant to healthcare stakeholders as the industry transitions to population health management, writes Joseph J. Fifer, president and CEO, HFMA.

Hospitals should balance their concern about achieving the margins they require to accomplish their missions with the need to maintain defensible pricing in an environment of increasing healthcare price transparency.

By harnessing, through sharing, the power of stories about experiences in meeting a dealing with issues and challenges, healthcare finance leaders can begin to find that place where passion meets purpose.

Myriad programs and legislative efforts in the ever-changing healthcare landscape have physicians and others in health care weary.